The ASNR-MICCAI Brain Tumor Segmentation (BraTS) Challenge 2023:
Intracranial Meningioma
- URL: http://arxiv.org/abs/2305.07642v1
- Date: Fri, 12 May 2023 17:52:36 GMT
- Title: The ASNR-MICCAI Brain Tumor Segmentation (BraTS) Challenge 2023:
Intracranial Meningioma
- Authors: Dominic LaBella, Maruf Adewole, Michelle Alonso-Basanta, Talissa
Altes, Syed Muhammad Anwar, Ujjwal Baid, Timothy Bergquist, Radhika Bhalerao,
Sully Chen, Verena Chung, Gian-Marco Conte, Farouk Dako, James Eddy, Ivan
Ezhov, Devon Godfrey, Fathi Hilal, Ariana Familiar, Keyvan Farahani, Juan
Eugenio Iglesias, Zhifan Jiang, Elaine Johanson, Anahita Fathi Kazerooni,
Collin Kent, John Kirkpatrick, Florian Kofler, Koen Van Leemput, Hongwei Bran
Li, Xinyang Liu, Aria Mahtabfar, Shan McBurney-Lin, Ryan McLean, Zeke Meier,
Ahmed W Moawad, John Mongan, Pierre Nedelec, Maxence Pajot, Marie Piraud,
Arif Rashid, Zachary Reitman, Russell Takeshi Shinohara, Yury Velichko,
Chunhao Wang, Pranav Warman, Walter Wiggins, Mariam Aboian, Jake Albrecht,
Udunna Anazodo, Spyridon Bakas, Adam Flanders, Anastasia Janas, Goldey
Khanna, Marius George Linguraru, Bjoern Menze, Ayman Nada, Andreas M
Rauschecker, Jeff Rudie, Nourel Hoda Tahon, Javier Villanueva-Meyer, Benedikt
Wiestler, Evan Calabrese
- Abstract summary: The BraTS meningioma 2023 challenge will provide a community standard and benchmark for state-of-the-art automated intracranial meningioma segmentation models.
Challenge competitors will develop automated segmentation models to predict three distinct meningioma sub-regions on MRI.
- Score: 4.435336201147607
- License: http://arxiv.org/licenses/nonexclusive-distrib/1.0/
- Abstract: Meningiomas are the most common primary intracranial tumor in adults and can
be associated with significant morbidity and mortality. Radiologists,
neurosurgeons, neuro-oncologists, and radiation oncologists rely on
multiparametric MRI (mpMRI) for diagnosis, treatment planning, and longitudinal
treatment monitoring; yet automated, objective, and quantitative tools for
non-invasive assessment of meningiomas on mpMRI are lacking. The BraTS
meningioma 2023 challenge will provide a community standard and benchmark for
state-of-the-art automated intracranial meningioma segmentation models based on
the largest expert annotated multilabel meningioma mpMRI dataset to date.
Challenge competitors will develop automated segmentation models to predict
three distinct meningioma sub-regions on MRI including enhancing tumor,
non-enhancing tumor core, and surrounding nonenhancing T2/FLAIR hyperintensity.
Models will be evaluated on separate validation and held-out test datasets
using standardized metrics utilized across the BraTS 2023 series of challenges
including the Dice similarity coefficient and Hausdorff distance. The models
developed during the course of this challenge will aid in incorporation of
automated meningioma MRI segmentation into clinical practice, which will
ultimately improve care of patients with meningioma.
Related papers
- BraTS-PEDs: Results of the Multi-Consortium International Pediatric Brain Tumor Segmentation Challenge 2023 [44.64458075448]
We present the results of the BraTS-PEDs 2023 challenge, the first Brain Tumor (BraTS) challenge focused on pediatric brain tumors.
BraTS-PEDs 2023 aimed to evaluate volumetric segmentation algorithms for pediatric brain gliomas from magnetic resonance imaging.
The top-performing AI approaches for pediatric tumor analysis included ensembles of nnU-Net and Swin UNETR, Auto3DSeg, or nnU-Net with a self-supervised framework.
arXiv Detail & Related papers (2024-07-11T20:35:32Z) - Brain Tumor Segmentation (BraTS) Challenge 2024: Meningioma Radiotherapy Planning Automated Segmentation [47.119513326344126]
The BraTS-MEN-RT challenge aims to advance automated segmentation algorithms using the largest known multi-institutional dataset of radiotherapy planning brain MRIs.
Each case includes a defaced 3D post-contrast T1-weighted radiotherapy planning MRI in its native acquisition space.
Target volume annotations adhere to established radiotherapy planning protocols.
arXiv Detail & Related papers (2024-05-28T17:25:43Z) - The 2024 Brain Tumor Segmentation (BraTS) Challenge: Glioma Segmentation on Post-treatment MRI [5.725734864357991]
The 2024 Brain Tumor (BraTS) challenge on post-treatment glioma MRI will provide a community standard and benchmark for state-of-the-art automated segmentation models.
Challenge competitors will develop automated segmentation models to predict four distinct tumor sub-regions.
Models will be evaluated on separate validation and test datasets.
arXiv Detail & Related papers (2024-05-28T17:07:55Z) - Analysis of the BraTS 2023 Intracranial Meningioma Segmentation Challenge [44.586530244472655]
We describe the design and results from the BraTS 2023 Intracranial Meningioma Challenge.
The BraTS Meningioma Challenge differed from prior BraTS Glioma challenges in that it focused on meningiomas.
The top ranked team had a lesion-wise median dice similarity coefficient (DSC) of 0.976, 0.976, and 0.964 for enhancing tumor, tumor core, and whole tumor.
arXiv Detail & Related papers (2024-05-16T03:23:57Z) - Cross-modality Guidance-aided Multi-modal Learning with Dual Attention
for MRI Brain Tumor Grading [47.50733518140625]
Brain tumor represents one of the most fatal cancers around the world, and is very common in children and the elderly.
We propose a novel cross-modality guidance-aided multi-modal learning with dual attention for addressing the task of MRI brain tumor grading.
arXiv Detail & Related papers (2024-01-17T07:54:49Z) - Fully Automated Tumor Segmentation for Brain MRI data using Multiplanner
UNet [0.29998889086656577]
This study evaluates the efficacy of the Multi-Planner U-Net (MPUnet) approach in segmenting different tumor subregions across three challenging datasets.
arXiv Detail & Related papers (2024-01-12T10:46:19Z) - The Brain Tumor Segmentation (BraTS) Challenge 2023: Focus on Pediatrics (CBTN-CONNECT-DIPGR-ASNR-MICCAI BraTS-PEDs) [4.119582963064813]
Pediatric tumors of the central nervous system are the most common cause of cancer-related death in children.
The five-year survival rate for high-grade gliomas in children is less than 20%.
The BraTS-PEDs 2023 challenge focuses on the development of volumentric segmentation algorithms for pediatric brain glioma.
arXiv Detail & Related papers (2023-05-26T15:40:11Z) - Integrative Imaging Informatics for Cancer Research: Workflow Automation
for Neuro-oncology (I3CR-WANO) [0.12175619840081271]
We propose an artificial intelligence-based solution for the aggregation and processing of multisequence neuro-Oncology MRI data.
Our end-to-end framework i) classifies MRI sequences using an ensemble classifier, ii) preprocesses the data in a reproducible manner, and iv) delineates tumor tissue subtypes.
It is robust to missing sequences and adopts an expert-in-the-loop approach, where the segmentation results may be manually refined by radiologists.
arXiv Detail & Related papers (2022-10-06T18:23:42Z) - Segmentation of the Myocardium on Late-Gadolinium Enhanced MRI based on
2.5 D Residual Squeeze and Excitation Deep Learning Model [55.09533240649176]
The aim of this work is to develop an accurate automatic segmentation method based on deep learning models for the myocardial borders on LGE-MRI.
A total number of 320 exams (with a mean number of 6 slices per exam) were used for training and 28 exams used for testing.
The performance analysis of the proposed ensemble model in the basal and middle slices was similar as compared to intra-observer study and slightly lower at apical slices.
arXiv Detail & Related papers (2020-05-27T20:44:38Z) - A Global Benchmark of Algorithms for Segmenting Late Gadolinium-Enhanced
Cardiac Magnetic Resonance Imaging [90.29017019187282]
" 2018 Left Atrium Challenge" using 154 3D LGE-MRIs, currently the world's largest cardiac LGE-MRI dataset.
Analyse of the submitted algorithms using technical and biological metrics was performed.
Results show the top method achieved a dice score of 93.2% and a mean surface to a surface distance of 0.7 mm.
arXiv Detail & Related papers (2020-04-26T08:49:17Z)
This list is automatically generated from the titles and abstracts of the papers in this site.
This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.